Other

Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year One

Caterpillar Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year One remained flat by 0.0% to $6.00M in Q4 2025 compared to the prior quarter. Over 2 years (FY 2023 to FY 2025), Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year One shows relatively stable performance with a 0.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryEfficiency
SignalHigher is better
VolatilityStable
First reportedQ4 2023
Last reportedQ4 2025Feb 13, 2026

How to read this metric

Higher receipts reduce the net cost of retiree benefits, improving cash flow, while lower receipts may indicate changes in subsidy eligibility or plan structure.

Detailed definition

This represents the expected cash inflows from government subsidies related to prescription drug benefits provided under...

Peer comparison

Common for large industrial firms with legacy pension and healthcare obligations.

Metric ID: other_prescription_drug_subsidy_receipts_next_twelve_months

Historical Data

3 periods
 Q4 '23Q4 '24Q4 '25
Value$6.00M$6.00M$6.00M
QoQ Change+0.0%+0.0%
YoY Change+0.0%+0.0%
Range$6.00M$6.00M
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak2+ quarters growth

Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year One at Other Companies

Frequently Asked Questions

What is Caterpillar's defined benefit plan, expected future prescription drug subsidy receipt, year one?
Caterpillar (CAT) reported defined benefit plan, expected future prescription drug subsidy receipt, year one of $6.00M in Q4 2025.
What is the long-term trend for Caterpillar's defined benefit plan, expected future prescription drug subsidy receipt, year one?
Over 2 years (2023 to 2025), Caterpillar's defined benefit plan, expected future prescription drug subsidy receipt, year one has grown at a 0.0% compound annual growth rate (CAGR), from $6.00M to $6.00M.
What does defined benefit plan, expected future prescription drug subsidy receipt, year one mean?
Expected government payments for retiree prescription drug costs over the next year.